220 Stocks to Sell Today
Free Report for Zacks.com
Visitors Only

Overall, Zacks Rank #5 Strong Sells perform 6X worse than the market. Are any of these portfolio killers lurking among the stocks you're holding or considering? Find out today for free.


No cost, no obligation to buy anything ever.
Privacy Policy
Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/19/2013

Company Name Symbol %Change
LUMOS NETWOR LMOS
4.77%
SONIC FOUNDR SOFO
4.40%
GREEN MOUNTA GMCR
3.71%
SHORETEL INC SHOR
3.49%
INGLES MARKE IMKTA
3.14%

Agrium Jumps on Higher View

by Zacks Equity Research

January 25, 2013 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Shares of leading fertilizer company Agrium Inc. (AGU - Analyst Report) shot up as it raised its earnings forecast for fourth-quarter 2012, citing a strong fall application season in North America and continued strength in grain and oilseed pricing. An extended fall season in the U.S. boosted the demand for its nutrients in the quarter.

The Canada-based company said that it now expects earnings (excluding one-time items) for the fourth quarter to be a tad higher than $2.00 per share. Earlier, it expected earnings of $1.50 to $1.90 per share. The current Zacks Consensus Estimate for the quarter is $1.69 per share.

The company envisions its Retail business unit to bring in more than $120 million of EBITDA (earnings before interest, taxes, depreciation, and amortization) in the fourth quarter. Its Wholesale segment is expected to generate EBITDA in excess of $500 million.

Agrium’s shares rose as high as $4.20 (or roughly 3.8%) following the announcement yesterday.

The company expects high crop prices and tight grain inventories to continue to create higher demand for its nutrients. It envisions strong demand for top quality seeds in the 2013 growing season.

Agrium stands to gain from rising crop prices and overall strong fundamentals for the agriculture and crop input market. The company follows a strategy to grow along the value chain through a combination of acquisitions and organic development.

The acquisition of AWB has expanded Agrium’s Retail division and provided access to the growing Southeast Asia market. Moreover, the acquisition of Viterra’s agri-products business is expected to support its earnings in 2013.

However, weak overseas potash demand stemming from the uncertainty associated with new supply contracts with China and India is impacting pricing for the nutrient and may affect overseas shipment volumes in the fourth quarter.

Agrium, which is among the prominent fertilizer companies along with CF Industries (CF - Analyst Report), Mosaic (MOS - Snapshot Report) and Potash Corp. (POT - Analyst Report), will report its fourth quarter and full-year 2012 results on Feb 22.

Agrium currently retains a short-term (1 to 3 months) Zacks Rank #3 (Hold).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.